These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 18687481
1. Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Gonzalo N, Cook S, Marra S, Moretti C, De Servi S, Palacios IF, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW. Int J Cardiol; 2009 Sep 11; 137(1):16-21. PubMed ID: 18687481 [Abstract] [Full Text] [Related]
2. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Cook S, Reardon L, Moretti C, De Servi S, Palacios IF, Windecker S, Colombo A, van Domburg R, Sheiban I, Serruys PW, DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol; 2008 Jun 10; 51(23):2212-9. PubMed ID: 18534266 [Abstract] [Full Text] [Related]
3. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry. Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ. J Am Coll Cardiol; 2009 Aug 25; 54(9):853-9. PubMed ID: 19695467 [Abstract] [Full Text] [Related]
4. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Catheter Cardiovasc Interv; 2006 Jul 25; 68(1):62-6. PubMed ID: 16755592 [Abstract] [Full Text] [Related]
7. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz KL, Dirschinger J, Schömig A, LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators. J Am Coll Cardiol; 2009 May 12; 53(19):1760-8. PubMed ID: 19422982 [Abstract] [Full Text] [Related]
9. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison. Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F. Minerva Cardioangiol; 2008 Feb 12; 56(1):35-42. PubMed ID: 18432167 [Abstract] [Full Text] [Related]
10. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. Valgimigli M, Malagutti P, Aoki J, Garcia-Garcia HM, Rodriguez Granillo GA, van Mieghem CA, Ligthart JM, Ong AT, Sianos G, Regar E, Van Domburg RT, De Feyter P, de Jaegere P, Serruys PW. J Am Coll Cardiol; 2006 Feb 07; 47(3):507-14. PubMed ID: 16458128 [Abstract] [Full Text] [Related]
11. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry). Roy P, Bonello L, de Labriolle A, Okabe T, Pinto Slottow TL, Steinberg DH, Torguson R, Smith K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. Am J Cardiol; 2008 Aug 01; 102(3):292-7. PubMed ID: 18638589 [Abstract] [Full Text] [Related]
12. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry. Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Nishikawa H, Nakao K, Shirota K, Kawai K, Hiasa Y, Kadota K, Nozaki Y, Isshiki T, Sone T, Mitsudo K, j-Cypher Registry Investigators. JACC Cardiovasc Interv; 2013 Jul 01; 6(7):654-63. PubMed ID: 23866178 [Abstract] [Full Text] [Related]
13. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group. Simonton CA, Brodie B, Cheek B, Krainin F, Metzger C, Hermiller J, Juk S, Duffy P, Humphrey A, Nussbaum M, Laurent S, STENT Group. J Am Coll Cardiol; 2007 Sep 25; 50(13):1214-22. PubMed ID: 17888837 [Abstract] [Full Text] [Related]
14. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent. Li JJ, Xu B, Yang YJ, Chen JL, Qiao SB, Ma WH, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL. Chin Med J (Engl); 2007 Apr 05; 120(7):569-73. PubMed ID: 17442204 [Abstract] [Full Text] [Related]
15. Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions. Ge L, Cosgrave J, Iakovou I, Qian JY, Agostoni P, Sangiorgi GM, Airoldi F, Michev I, Chieffo A, Corvaja N, Colombo A, Ge JB. Chin Med J (Engl); 2007 Apr 05; 120(7):545-51. PubMed ID: 17442200 [Abstract] [Full Text] [Related]
16. Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries. Tanimoto S, Daemen J, Tsuchida K, García-García HM, de Jaegere P, van Domburg RT, Serruys PW. Catheter Cardiovasc Interv; 2007 Jan 05; 69(1):94-103. PubMed ID: 17139687 [Abstract] [Full Text] [Related]
17. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Kumar S, Suresh V, Prendergast BD, Brooks NH, Wicks P, Levy RD, Ray SG, Bennett DH, Lee HS. Catheter Cardiovasc Interv; 2006 Nov 05; 68(5):663-8. PubMed ID: 17034063 [Abstract] [Full Text] [Related]
18. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. JACC Cardiovasc Interv; 2013 Dec 05; 6(12):1242-9. PubMed ID: 24355114 [Abstract] [Full Text] [Related]
19. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions. Kim YH, Park SW, Lee CW, Hong MK, Gwon HC, Jang Y, Lee MM, Koo BK, Oh DJ, Seung KB, Tahk SJ, Yoon J, Park SJ. Catheter Cardiovasc Interv; 2006 Feb 05; 67(2):181-7. PubMed ID: 16400663 [Abstract] [Full Text] [Related]
20. Treatment of left main coronary trifurcation lesions with the paclitaxel drug-eluting stent: mid-term outcomes from a tertiary medical center. Shammas NW, Shammas GA, Jerin M, Parikh A, Coin K, Dippel E, Sharis P, Robken J. J Invasive Cardiol; 2009 Jul 05; 21(7):321-5. PubMed ID: 19571341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]